NMR analysis of the correlation of metabolic changes in blood and cerebrospinal fluid in Alzheimer model male and female mice.
The development of effective therapies as well as early, molecular diagnosis of Alzheimer's disease is impeded by the lack of understanding of the underlying pathological mechanisms. Metabolomics studies of body fluids as well as brain tissues have shown major changes in metabolic profiles of A...
Guardado en:
Autores principales: | Filip Stojanovic, Mariam Taktek, Nam Huan Khieu, Junzhou Huang, Susan Jiang, Kerry Rennie, Balu Chakravarthy, Will J Costain, Miroslava Cuperlovic-Culf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7ca410966c494c238d0e4caf8e431b64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
por: Richard J Perrin, et al.
Publicado: (2011) -
Cerebrospinal fluid research
Publicado: (2004) -
A Luminex assay detects amyloid β oligomers in Alzheimer's disease cerebrospinal fluid.
por: Adrianna Z Herskovits, et al.
Publicado: (2013) -
Anaemia and cerebrospinal fluid biomarkers of Alzheimer’s pathology in cognitively normal elders: the CABLE study
por: Xin-Yu Yang, et al.
Publicado: (2021) -
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease
por: María-Salud García-Ayllón, et al.
Publicado: (2017)